Expression of adrenomedullin and proadrenomedullin N-terminal 20 peptide in human and rat prostate by Jimenez, N. (Nuria) et al.
 © The Histochemical Society, Inc.
 
0022-1554/99/$3.30
 
1167
 
ARTICLE
 
Volume 47(9): 1167–1177, 1999
The Journal of Histochemistry & Cytochemistry
 
http://www.jhc.org
 
Expression of Adrenomedullin and Proadrenomedullin 
N-terminal 20 Peptide in Human and Rat Prostate
 
Nuria Jiménez, Alfonso Calvo, Alfredo Martínez, David Rosell, Frank Cuttitta,
and Luis M. Montuenga
 
Department of Histology and Pathology, University of Navarra, Pamplona, Spain (NJ,AC,LMM); Department of Cell
and Cancer Biology, National Cancer Institute, Bethesda, Maryland (AM,FC,LMM); and Department of Urology,
University of Navarra, Pamplona, Spain (DR)
 
SUMMARY
 
Adrenomedullin (AM) and proadrenomedullin N-terminal 20 peptide (PAMP)
are two recently discovered hypotensive peptides translated from the same message tran-
script (preproAM mRNA). In this article we report the presence of AM, PAMP, and their
mRNA in human and rat prostate and of AM receptor mRNA in rat prostate. PreproAM
mRNA was found in the epithelium of normal human and rat prostate glands by in situ hy-
bridization. In humans, it was mainly expressed in the basal cells. In rat, its expression was
higher in the ducts than in the acini of all the prostate lobes. Immunocytochemistry identi-
fied a similar distribution pattern for AM compared with its mRNA but showed different lo-
cations for AM and PAMP immunoreactivity. The former was widespread in the epithelia,
whereas the latter was almost exclusively found in neuroendocrine cells. In rat, Western
blot analysis confirmed the presence of high levels of AM peptide in the ventral lobe and
of its precursor in the ventral and dorsolateral lobes. Immunoreactivity for serotonin, chro-
mogranin A, PAMP, and AM defined four subpopulations of prostate neuroendocrine-like
cells in rat, a cell type that has not been previously described.
 
(J Histochem Cytochem 47:1167–1177, 1999)
 
A
 
drenomedullin
 
 (AM) and proadrenomedullin
N-terminal 20 peptide (PAMP) are two recently identi-
fied peptides with pluripotent function (Kitamura et al.
1993a,b). Both are amidated peptides (52 and 20 amino
acids, respectively) originated by post-translational enzy-
matic processing of a single 185-amino-acid precursor,
preproAM (Kitamura et al. 1993b, 1994). Human and
rat AM consist of 52 and 50 amino acids, respectively,
and show a very high homology (Kitamura et al. 1993a;
Sakata et al. 1993). Rat and human PAMP are almost
identical in their 20 amino acid residues. The sequence of
AM bears some homology with calcitonin gene-related
peptide (CGRP) and amylin but not with PAMP. Re-
cently, receptors for AM (AM-R) have been cloned and
sequenced (Kapas et al. 1995), and binding sites for
PAMP have been localized (Iwasaki et al. 1996).
AM and PAMP are expressed in a variety of normal
mammalian cells and organs showing enhanced ex-
pression during certain pathological states. In the
adrenals, heart, and other cardiovascular tissues, the
highest levels of these peptides have been reported (for
a review see Montuenga et al. 1998). AM-R has been
localized by in situ hybridization in different tissues
(Martínez et al. 1997b; Montuenga et al. 1997).
Initially, it was demonstrated that AM and PAMP
were potent vasodilators, but a number of additional
roles have recently been attributed to these peptides.
For example, AM may act as an autocrine growth fac-
tor (Miller et al. 1996), an apoptosis survival factor
(Kato et al. 1997), a neurotransmitter (Allen and Fer-
guson 1996), a bronchodilator (Kanazawa et al. 1995),
and an antimicrobial agent (Walsh et al. 1996). AM
has also been reported to control hormone secretion
(Martínez et al. 1996) or renal homeostasis (Massart
et al. 1996). PAMP appears to be involved in inhibi-
tion of neurotransmission (Shimosawa et al. 1995) and
also acts as a bronchodilator (Kanazawa et al. 1995),
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an antimicrobial agent (Walsh et al. 1996), and a growth
suppressor (Ando et al. 1997).
There are no studies on the expression of AM, AM-R
and PAMP in the male urogenital tract, although some
physiological reports on the effect of AM in penile
erection have recently been published (Champion et
al. 1997). The human prostate consists of compound
glands connected to the prostatic urethra and sur-
rounded by a fibromuscular stroma. The ejaculatory
ducts and the utriculus prostaticus are included among
the glands, which are disposed concentrically around
the urethra. Throughout the entire glandular epithe-
lium of the human prostate, three cell types can be dis-
tinguished (Luke and Coffey 1994): basal or stem cells,
with proliferative ability; secretory or principal cells,
which secrete prostate fluid; and neuroendocrine (NE)
cells, which produce bioactive amines such as seroto-
nin and neuropeptides (Luke and Coffey 1994). NE
cells are scant and are scattered throughout the epithe-
lium of the glands, the urethra, and the utriculus. It
has been suggested that they might be involved in the
regulation of the proliferation of their surrounding
cells via secretion of paracrine factors (Di Sant’Agnese
and Cockett 1996).
Despite some biochemical, embryological, histolog-
ical, and functional differences compared to the hu-
man prostate (Price 1973), the rat prostate has been
widely used as a model to study prostate biology and
pathology (Pollard 1992; Nishi et al. 1996). In the rat,
the prostate is closely related to the ampullary glands,
the ejaculatory ducts, and the urethra (Jesick et al.
1982). The rat prostate is composed of glands dis-
posed in one dorsal, two lateral, and two ventral lobes
around the urethra (Jesick et al. 1982). Each dorsal
and lateral gland consists of a proximal duct, from
which originate many distal ducts or acini (Hayashi et
al. 1991). Ventral glands have also a proximal duct,
which branches out into intermediate ducts (Lee et al.
1990) which, in turn, branch further into acini. The
proximal ducts of all lobes are connected to the ure-
thra (Jesick et al. 1982). These connections and the
urethra are immersed in a thick fibromuscular stroma,
all constituting the urethral ring. However, in the ven-
tral lobes, distal segments of the proximal ducts spread
out of the urethral ring. Principal and basal cells are
found in the rat prostate epithelium. Principal cells are
secretory in nature and may proliferate, and basal cells
are scarce and also can divide (English et al. 1987). To
our knowledge, NE cells have not yet been described
in rat prostate.
The objective of the present work was to study the
expression of AM, AM-R, and PAMP in the different
cell populations of human and rat prostate. The re-
sults reported here suggest that AM and PAMP play
a relevant role in the physiology of rat and human
prostate.
 
Materials and Methods
 
Tissue Samples and Processing
 
Control human prostates were obtained from autopsies of
healthy young individuals (17 and 23 years old) killed in
traffic accidents (kindly donated by Dr. Luis Santamaría;
Department of Morphology, Autonomous University of
Madrid, Spain). All tissue procurement protocols were ap-
proved by the relevant institutional committees. Prostates
were fixed in 10% formalin, dehydrated in alcohols, and
embedded in paraffin. Sections 3 
 
m
 
m thick were obtained
and placed on slides previously treated with Vectabond
(Vector Laboratories; Burlingame, CA) for immunocy-
tochemistry, and on ProbeOn Plus slides (Fisher Scientific;
Pittsburgh, PA) for in situ hybridization (ISH). Some re-
verse-face sections were prepared to assess co-localization of
immunoreactivity.
Adult Wistar rats from the colony kept at the University
of Navarra were used. Animals were treated according to the
ethical standards approved by our institution. Rats were an-
esthesized by inhalation of ether and decapitated. The uro-
genital tracts were exposed by abdominal incision and
quickly removed. Prostates and the related structures (e.g.,
ampullary glands) were immersed in 10% formalin or in
Bouin’s fluid for 24 hr. After fixation, the organs were cut
sagittally, dehydrated, and processed like the human tissues.
Some rat prostates were immediately frozen in liquid N
 
2
 
 to
carry out RT-PCR and Western blot techniques. Ventral and
dorsolateral lobes were separately processed for Western
blotting.
 
Antibodies and Optimal Dilutions
 
Immunoreactivity for AM was demonstrated using a poly-
clonal antiserum (no. 2469) raised in rabbits to the synthetic
peptide P072 (AM
 
22–52AMIDE
 
). This antiserum was obtained
from consecutive bleeds of the rabbit from which the antise-
rum no. 2343 was obtained (Martínez et al. 1995) and
shares its immune properties. Different dilutions of the AM
antiserum were tested (from 1:200 to 1:600). The optimal
dilution was 1:200 in human and rat prostates. The same
antiserum was used for Western blotting at 1:1,000.
To localize PAMP, one polyclonal antiserum (no. 2463)
was used at 1:1000 for rat, and 1:4000 for human tissues.
This antiserum was raised to the C-terminal peptide P070
(PAMP
 
YY13–20AMIDE
 
), which consists of eight common amino
acids for human and rat peptides. The antiserum has been
previously characterized (Montuenga et al. 1997). The anti-
serum no. 2463 was also used for Western blotting at 1:800.
Two monoclonal antisera raised against human chro-
mogranin A were used to detect this protein. One of them
(Boehringer; Mannheim, Germany) was used at a concentra-
tion of 2 
 
m
 
g/ ml for human tissues and 15 
 
m
 
g/ ml for rat. The
other (Novocastra Laboratories; Newcastle, UK) was used
at 1:50 from the commercial stock. Serotonin was demon-
strated with a polyclonal antiserum (Incstar; Stillwater,
MN), at 1:200,000 in human tissues and 1:125,000 in rats.
 
Immunocytochemistry
 
Sections were deparaffinized, rehydrated, and endogenous
peroxidase was inhibited in a 3% H
 
2
 
O
 
2
 
 solution in deion-
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ized H
 
2
 
O for 10 min. A microwave pretreatment was ap-
plied for antigen retrieval. Sections were immersed in 0.01
M citric acid (Sigma Chemical; St Louis, MO) buffer, pH 6,
and heated for 10 min at 750 W, followed by 10 min at 375
W. Then the slides were cooled in running water. Tissues
were blocked with normal rabbit serum (1:20) when mono-
clonal antisera were used or with normal swine serum (1:20)
when polyclonal antisera were applied. Then the tissues
were incubated overnight with the specific antiserum at 4C.
After washes with Tris-buffered saline (TBS), sections were
incubated for 1 hr in 1:100 biotinylated swine (against rab-
bit Fc; Dako, Glostrup, Denmark) or rabbit (against mouse
Fc; Dako) IgG, according to the antibody employed. Slides
were treated with the avidin–biotin–peroxidase complex
(ABC; Dako) diluted 1:100 for 1 hr. Peroxidase activity was
detected with 3-3
 
9
 
-diaminobenzidine hydrochloride (DAB)–
H
 
2
 
O
 
2
 
 and slides were the counterstained with Harris’ hema-
toxylin, dehydrated, and mounted in DPX.
Absorption controls were used to test the specifity of the
antisera. Solutions containing the optimal dilution of each
specific antiserum preincubated with its respective peptide
(P070, P072, serotonin; Sigma) at 10 nmol/ml were applied
to the slides instead of the primary antiserum. The chromo-
granin A peptides were not available.
 
Immunocytochemical Double Staining
 
Sections were deparaffinized, rehydrated, and endogenous
peroxidase was inhibited. They were also microwave-pre-
heated as described above. Slides were incubated with a nor-
mal sera mixture (1:30 goat, 1:20 swine), and incubated at
4C overnight with the specific antisera (monoclonal and
polyclonal) mixture. Then the slides were covered with bio-
tinylated swine anti-rabbit antiserum (Dako), and goat
anti-mouse antiserum (Dako), both diluted 1:100, for 1 hr.
Tissues were treated with monoclonal alkaline phosphatase–
anti-alkaline phosphatase (APAAP, mouse monoclonal; Dako)
and ABC at 1:50 and 1:100, respectively, for 1 hr. Goat anti-
mouse antiserum was applied again, followed by APAAP,
for 10 min each. The alkaline phosphatase (AP) was re-
vealed using naphthol AS-TR and New Fuchsin as substrate,
which produced a red endproduct. Peroxidase was revealed
with DAB and nickel enhancement to give a black endprod-
uct (Montuenga et al. 1992). Slides were mounted in PBS–
glycerol.
 
Western Blotting
 
Prostates were homogenized in a buffer containing 50 mM
NaCl, 25 mM Tris-HCl (pH 8.1), 0.5% Nonidet P-40,
0.5% sodium deoxicholate, 1 mM phenyl-methyl-sulfonyl-
fluoride (PMSF), 10 
 
m
 
g/ml leupeptin, 25 
 
m
 
g/ml aprotinin,
and 10 
 
m
 
g/ml pepstatin. Tissues were then clarified by ultra-
centrifugation, and the final protein concentration was de-
termined (BCA kit; Pierce, Rockford, IL). Protein extracts
were diluted to an approximate protein concentration of 35
 
m
 
g/50 
 
m
 
l, heated to 95C for 3 min, and loaded into the sam-
ple well. Tissue protein extracts were electrophoretically
separated on a gradient 10–20% tricine SDS-PAGE gel
(Novex; San Diego, CA), and run at 100 V for 2 hr under re-
ducing (5% 
 
b
 
-mercaptoethanol) conditions. Synthetic AM
0.5 ng or PAMP 5 ng was added to separate wells as positive
controls. Transfer blotting was accomplished in the same
apparatus equipped with a titanium plate electrode and
transferred to a polyvinyldifluoride membrane (Immobilon
PVDF; Millipore, Bedford, MA) at 30 V for 3 hr. The mem-
branes were blocked overnight in 1% BSA–PBS, incubated
for 1 hr in a 1:1000 dilution of rabbit anti-AM or 1:800 of
rabbit anti-PAMP, washed three times in PBS, exposed to 1 
 
3
 
10
 
6
 
 cpm [
 
125
 
I]-protein A for 30 min at 4C, washed six times
in PBS, dried, and autoradiographed overnight at 
 
2
 
80C on
Kodak XAR5 film.
Solutions containing each specific antiserum preincu-
bated with its respective peptide (P070, P072) at 10 nmol/ml
were applied to the membrane instead of the primary antise-
rum and served as the absorption control.
 
Riboprobes
 
An 831-bp cDNA encoding for a fragment of preproAM
was obtained from human adrenal mRNA by RT-PCR using
the following primers: 5
 
9
 
-TAC-CTG-GGT-TCG-CTC-GCC-
TTC-CTA-3
 
9
 
and 5
 
9
 
-CTC-CGG-GGG-TCT-CAG-CAT-TCA-
TTT-3
 
9
 
. The PCR product was sequenced to ensure homol-
ogy with the published cDNA (Genbank accession number:
D14874) (Kitamura et al. 1993b).The amplified cDNA was
ligated in both sense and antisense orientation into the ex-
pression vector pcDNA3 (Invitrogen; San Diego, CA) at the
EcoRI site, following the manufacturer’s instructions. SP6
promoter was used for generation of sense and antisense ri-
boprobes to avoid differences in the in vitro transcription
rate and efficacy. The sense or antisense plasmid was linear-
ized with BamHI and used as a template to synthesize anti-
sense or sense transcript, respectively, using SP6 RNA poly-
merase. Probe transcription was carried out at 37C for 2 hr.
One 
 
m
 
g of DNA template, nucleotides (including digoxigenin-
UTP), 80 U of SP6 RNA polymerase (all from Boehringer),
and 40 U of RNase inhibitor (RNasin Ribonuclease Inhibi-
tor; Promega, Madison, WI) were used. Riboprobes were
precipitated with ethanol at 
 
2
 
20C and resuspended in H
 
2
 
O
treated with diethilpirocarbonate (DEPC; Sigma) containing
40 U of RNasin.
 
In Situ Hybridization
 
The protocol followed was similar to that applied by García
et al. (1998). Sections of formalin-fixed human or rat pros-
tate were deparaffinized, rehydrated, and permeabilized in
0.2% Triton–PBS for 15 min. Rat tissues were digested at
37C with a proteinase K solution (10 
 
m
 
g/ml) in 0.1 M Tris–
50 mM EDTA, pH 8, for 30 min. Human tissues were mi-
crowave-preheated as explained for immunocytochemistry
and then incubated with proteinase K (5 
 
m
 
g/ml) at 37C for
15 min. Digestions were stopped in 0.1 M glycine–PBS. Tis-
sues were acetylated with 0.25% acetic anhydride in 0.1 M
triethanolamine, pH 8, washed in DEPC–H
 
2
 
O, and air-dried
at room temperature.
Hybridization with antisense probe (50 ng/
 
m
 
l hybridiza-
tion buffer) was performed overnight at 43C in a moist
chamber. Three stringency washes were carried out and then
the slides were treated with RNase A (20 
 
m
 
g/ml) at 37C for
15 min. Sections were incubated for 2 hr with 1:500 anti-
digoxigenin antiserum labeled with AP (Boehringer). Nitro-
blue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl
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phosphate (Boehringer) were used to visualize AP activity
(Polak and Van Noorden 1987). Slides were mounted in
glycerol–PBS.
Two types of negative controls were used: the application
of (a) the sense probe (50 ng/
 
m
 
l) instead of the antisense, and
(b) mixtures of labeled antisense probe (50 ng/
 
m
 
l) with in-
creasing concentrations (from 50 to 200 ng/
 
m
 
l) of unlabeled
antisense probe.
 
RNA Extraction and RT-PCR
 
Total rat prostate RNA was obtained with the Ultraspec
RNA Kit (Biotecx; Houston, TX), according to the manu-
facturer’s instructions. The RNA concentration was spectro-
photometrically determined. RNA was retrotranscribed with
M-MLV reverse transcriptase (Gibco BRL; Paisley, UK). The
sets of primers employed to detect mRNA of AM and AM-R
through the polymerase chain reaction (PCR) are shown in
Table 1. PCR was performed as previously described (Mon-
tuenga et al. 1997), using a P-E Thermocycler-2,400 (Per-
kin–Elmer; Foster City, CA) at 94C for 15 sec, 55C for 15
sec, and 72C for 1 min, for 35 cycles. PCR products were
run in 2% agarose gels and scanned with a Molecular Ana-
lyst Biorad Laboratories Machine (Biorad; Hercules, CA),
equipped with the Windows Software for Biorad’s Image
Analyzer Systems 1.4. The images were transformed into a
TIFF format for printing.
 
Results
 
Immunocytochemistry in Human Prostate
 
In the human tissues, labeling for AM was found
mainly in the basal cells of the glandular epithelium
(Figure 1) and the utriculus. AM was also found in the
entire epithelium of the urethra, ejaculatory ducts, and
squamous glands. Some cells of the stroma, endothe-
lial cells, and nerves were also stained. Labeling was
absent in absorption controls (Figure 2).
Strong positivity for PAMP was found in scattered
cells throughout the epithelium of the glands (Figure
3), the utriculus, and the urethra. Most of them were
located in the utriculus. These cells were more numer-
ous in the glands of the central zone of the prostate
than in the glands localized in the peripheral zone.
The cells were either dendritic or nondendritic. Dou-
ble immunolabeling for PAMP and chromogranin A
confirmed these cells as neuroendocrine (Figures 4A
and 4B). Immunostaining of reverse-face sections dem-
onstrated that PAMP-labeled cells were also stained
for serotonin. However, not all the serotonin- or chro-
mogranin A-immunolabeled cells were positive for
PAMP (Figure 4B). Absorption controls confirmed the
specificity of the immunostaining reactions.
 
Immunocytochemistry in Rat Prostate
 
In sections from rat prostate fixed in formalin and in-
cubated with the anti-AM antiserum, the results were
as follows. In the lateral lobes, the immunoreactivity
was localized in the apical cytoplasm and in perinu-
clear areas of the secretory cells of the acinar epithe-
lium (Figure 5). In the ventral prostate acini, only
some cells with apical nuclei exhibited AM reactivity.
In the dorsal lobe, a granular pattern of staining was
found in the principal cells of the acini and in the lu-
minal desquamated cells. AM immunoreactivity in the
epithelial cells of the proximal ducts of all the lobes
and in the ventral intermediate ducts was more intense
than that observed in the acini. AM was homoge-
neously distributed throughout the cytoplasm of these
cells. A small population of very intensely marked
cells was scattered throughout the epithelium of the
proximal ducts of all the lobes, the urethra and, less
prominently, the ventral acini. These cells were oval
and sometimes presented fine cytoplasmic extensions
(Figure 6). Epithelial cells of the ampullary glands,
urethra, and ureters were homogeneously stained for
AM. Epithelial cells of the ejaculatory ducts were also
immunoreactive and exhibited a granular pattern lo-
calized mainly in the upper half of the cells. The en-
dothelial cells, some neurons of the associated ganglia,
and some stromal (mainly smooth muscle) cells situ-
ated around the ducts in the periurethral zone were
also positive for AM.
Absorption controls resulted in quenching of all
AM staining except for that found in the scattered
cells strongly stained. When a threefold (with respect
to the optimal) dilution of the primary antibody was
used, only these cells remained labeled (Figure 6), and
the absorption control resulted in a total absence of
labeling.
Strong immunoreactivity for PAMP was found in
some dispersed cells of the epithelium of the proximal
ducts of the lateral (Figure 7A), dorsal and ventral
lobes. These PAMP-positive cells were also present in
the epithelium of the urethra and, less frequently, of
the ventral and dorsal acini. The distribution and
shape of these cells were similar to those of the scat-
tered AM-immunoreactive cells. However, reverse-
face sections demonstrated that AM- and PAMP-
immunoreactive cells are two different subpopulations
because the immunoreactivities for both peptides do
not co-localize in the same cells (Figures 7A and 7B).
 
Table 1
 
Sequences of the oligonucleotides used for RT-PCR
 
Adrenomedullin (expected size 291 bp in human; 282 bp in rat)
Sense (250–270) 5
 
9
 
-AAG-AAG-TGG-AAT-AAG-TGG-GCT-3
 
9
 
Antisense (521–540) 5
 
9
 
-TGT-GAA-CTG-GTA-GAT-CTG-GT-3
 
9
 
Adrenomedullin receptor (expected size 793 bp)
Sense (687–706) 5
 
9
 
-ACC-AAT-ACC-TCT-CCC-TCC-TG-3
 
9
 
Antisense (1462–1479) 5
 
9
 
-TGG-CAT-CCC-CCT-CT(CG)-AAC-3
 
9
 
Adrenomedullin receptor (expected size 185 bp)
Sense (1295–1314) 5
 
9
 
-GCA-CTC-CAT-CAT-CAT-TAC-CA-3
 
9
 
Antisense (1462–1479) 5
 
9
 
-TGG-CAT-CCC-CCT-CT(CG)-AAC-3
 
9
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PAMP reactivity was also present in some ganglion
perisomatic glial cells. Negative controls confirmed
the specifity of the immunostaining for PAMP in all
cases.
To characterize the nature of the AM- and PAMP-
positive cells in the rat prostate, double immunocy-
tochemistry (using anti-chromogranin A antisera) and
immunocytochemistry in reverse-face sections (with
anti-serotonin antiserum) was performed. A wide pop-
ulation of serotonin-positive cells was demonstrated
dispersed in the epithelium of the urethra and the
proximal ducts of all prostate lobes (Figure 8A). They
were very rarely observed in the ventral acinar epithe-
lium (i.e., one or two positive cells in the ventral lobes
per sagittal section). The shape of these cells varied
from oval to dendritic, the last resembling the typical
NE cell type. Absorption controls resulted in lack of
staining. In reverse-face sections, cells immunolabeled
for PAMP were also serotonin-positive; however, not
all the serotonin-positive cells were labeled for PAMP
(Figures 8A and 8B). There was no co-localization of
AM and serotonin in the same cells. With two differ-
ent antisera, the presence of scattered chromogranin
A-positive cells was observed in the epithelium of the
urethra and the proximal ducts of all the lobes. The
chromogranin A-immunoreactive cells were less nu-
merous than serotonin-positive cells. These cells ap-
peared oval and sometimes exhibited cytoplasmic
elongations. None of the chromogranin A-immunore-
active cells were simultaneously stained for AM or for
PAMP, although a clear co-localization with serotonin
was observed.
Fixation with Bouin’s fluid enhanced the intensity
of the immunoreactivity for all antibodies in the endo-
crine-like cells as compared to formalin. However, the
rest of the cells labeled for AM were not stained in
Bouin’s-fixed tissues.
All the results described here were obtained in sec-
tions subjected to microwave treatment. The same im-
munoreactivities were observed in non-preheated rat
Figure 1 AM immunoreactivity in the
basal zone of human prostate gland.
Bar 5 17 mm.
Figure 2 Absorption control for AM
in human prostate. Bar 5 17 mm.
Figure 3 PAMP staining in human
prostate. Bar 5 7 mm.
Figure 4 (A,B) Double immunocyto-
chemistry for PAMP and chromogra-
nin A in human prostate. A garnet
color results from the co-localization
of both red (for chromogranin A) and
black (for PAMP) precipitates. There is
a red cell positive only for chromogra-
nin A (arrowhead). Bars 5 17 mm
Figure 5 Rat lateral lobe acinus
stained for AM. Immunolabeling is
found in the epithelium. Bar 5 17 mm.
Figure 6 AM-positive cells in a rat
proximal duct draining the lateral
lobe. Bar 5 17 mm.
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and human sections, with the antibodies used at a
higher concentration. However, microwave preheat-
ing was indispensable to obtain reactivity for chro-
mogranin A in rat prostate.
 
Western Blotting of Rat Prostate Protein Extracts
 
Total protein extracts from dorsolateral and ventral
rat lobes were separately studied. Two immunoreac-
tive bands for AM were found, one of approximately
14 kD and a second one, found only in the extracts
from ventral prostate, of 6 kD (Figure 9A). The 6-kD
band found in the ventral prostate co-migrates with
the synthetic AM used as control (Figure 9A). Absorp-
tion control, with the same antigen used to raise the
antibody, completely abolished the immunoreaction
(Figure 9B). When the same protein extracts were run
and analyzed for PAMP immunoreaction, no bands
were found (not shown).
 
In Situ Hybridization in Human and Rat Prostate
 
In human tissues, hybridization with the preproAM
antisense riboprobe resulted in the staining of the
basal cells in most of the glands (Figure 10) and in the
utriculus. AM mRNA was also homogeneously distrib-
uted in the epithelial cells of the urethra, ejaculatory
ducts, and glands exhibiting squamous epithelium. The
stroma did not exhibit any staining. Incubations with
mixtures of labeled and unlabeled antisense probes re-
sulted in a decrease of the staining directly dependent
on the proportion of unlabeled probe.
In rat prostate, hybridization with the antisense
probe revealed the presence of AM mRNA in the epi-
Figure 7 Serial reverse-face sections
of rat prostate lateral proximal ducts
stained for (A) PAMP and (B) AM. Ar-
rowheads point to the same cell in
the epithelium. Bars 5 20 mm.
Figure 8 Serial reverse-face sections
of rat prostate dorsal proximal ducts
stained for (A) serotonin and (B)
PAMP. The same cells in both sections
are marked with the same type of ar-
row. Note that the cell marked with
arrowheads is positive for serotonin
but not for PAMP. Bars 5 12.5 mm.
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thelial cells of the lateral acini, where the maximal la-
beling was found (Figures 11 and 12), in most cells of
the dorsal acini (including desquamated cells), and in
some ventral acinar epithelial cells (most of them with
apical nuclei). Some neurons in the associated ganglia
(Figure 13) and endothelial cells of most vessels were
also stained. AM mRNA was also found in the epithe-
lium of ampullary glands (Figure 15), proximal ducts
of all prostate lobes, and ventral intermediate ducts,
all showing strong positivity. Epithelial cells of ejacu-
latory ducts, urethra, and ureters were also labeled.
Rat prostate incubated with mixtures of labeled and
unlabeled antisense probes showed the same reduction
of staining described for human prostate sections. In
the tissues treated with the sense probe, labeling was
absent (Figure 14).
In our hands, the optimal pretreatments for ISH in
the prostate sections are as follows: (a) for human tis-
sues, application of microwaves and proteinase K. Pre-
treatments with only proteinase K or only microwaves
did not produce any staining; (b) in rat prostate, in-
cubation with proteinase K was critical. Treatments
with only microwaves or microwaves with proteinase
K decreased the labeling in most zones. In both spe-
cies, when sections were preincubated with only pro-
teinase K, high background staining appeared in the
stroma. This background was observed even when
the sections were incubated with hybridization buffer
alone. Nevertheless, this nonspecific staining did not
appear in the sections of both species when microwave
treatment was applied.
 
RT-PCR of Rat Prostate mRNA Extracts
 
In rat prostate, a 282-bp PCR product was detected
after amplification with the human AM primers, dem-
onstrating the presence of mRNA for preproAM (Fig-
ure 16A). Using two sets of primers to detect mRNA
for AM-R, we also found the expected 185- and 793-
bp PCR products (Figure 16B).
 
Discussion
 
Since its initial identification in a human pheochro-
mocytoma, AM has been shown to be expressed in a
variety of tissues (Ichiki et al. 1994; Satoh et al. 1995).
In this work we demonstrate that AM and its gene-
related peptide, PAMP, are also present in normal
human and rat prostate, as determined by several ana-
lytical techniques. In rat prostate extracts, we have
also detected by RT-PCR the expression of the AM-R
mRNA.
AM is widely distributed in normal human and rat
prostate, mainly in the epithelial compartment. Immu-
nocytochemistry and ISH analysis show a parallel pat-
tern of distribution for protein and mRNA.
In rat, the expression of AM depends on the zone
of the gland, with the lateral lobes having the greatest
amounts of mRNA and protein. The proximal ducts
of all prostate lobes exhibit a higher expression than
the acini, as revealed by immunocytochemistry and
ISH. Lobe-specific differences in AM expression are
also shown by Western blotting. A single 14-kD band,
which may correspond to one of the AM precursors, is
found for dorsolateral lobes, whereas bands of 14-
and 6-kD (the latter corresponding to fully processed
AM) are observed in the ventral lobe. This difference
suggests a region-specific post-translational processing
of the precursor preproAM in the ventral lobe vs dor-
solateral prostate or the rapid secretion or degrada-
tion of this 6-kD entity in dorsolateral prostate. It is
noteworthy that the protein extracts of dorsolateral or
ventral lobes used to perform the Western blotting did
not include the same portion of ducts; the dorsolateral
prostate included mainly acini, whereas the extracts of
ventral lobes included not only acini but also interme-
diate ducts and a segment of proximal ducts. On the
basis of the results of the Western blot study, it is
likely that the AM-like material detected by immuno-
cytochemistry in rat acini is mainly preproAM, which
could represent a storage form. However, the more in-
tense immunolabeling detected in proximal ducts of
all the lobes and in the ventral intermediate ducts could
represent both preproAM and fully processed AM.
AM is involved in cell growth (Miller et al. 1996),
epithelial repair (Martínez et al. 1997a,b), and antimi-
crobial activities (Walsh et al. 1996), and all these ac-
tivities may be relevant in prostate physiology. It has
been suggested that AM may act as an autocrine/para-
crine growth factor (Miller et al. 1996; Montuenga et
al. 1997). The widespread distribution of AM in the
prostate and the presence in the same tissue of the
mRNA for the AM-R (at least in rat) are consistent
with the possibility that is a regulator of prostate cell
growth.
AM also acts in the control of smooth muscle con-
traction, therefore regulating vasodilatation (Heaton
et al. 1995) and bronchodilatation (Kanazawa et al.
Figure 9 (A) Western blotting detecting AM (6-kD band) in rat
ventral prostate and preproAM (14-kD band) in rat ventral and
dorsolateral prostate. (B) Absorption control. VP, ventral prostate;
DP, dorsolateral prostate.
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Figure 10 ISH localizing the preproAM mRNA in the human normal prostate. Bar 5 40 mm.
Figure 11 Detection of mRNA for preproAM in the lateral lobe acinar epithelium of the rat. Bar 5 40 mm.
Figure 12 Detail of Figure 13 showing strong labeling in the cytoplasm but not in the nuclei of the prostate cells. Bar 5 20 mm.
Figure 13 ISH using the antisense riboprobe in a nerve ganglion associated with the rat prostate. Bar 5 40 mm.
Figure 14 ISH performed with the sense riboprobe of preproAM mRNA in rat prostate as a negative control. Labeling is absent from the
lateral lobe acinar epithelium. Bar 5 20 mm.
Figure 15 PreproAM mRNA detected in the rat ampullary gland epithelium. Bar 5 40 mm.
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1995). In the rat, AM is especially abundant in the ep-
ithelial cells of all the proximal ducts and the ventral
intermediate ducts, which are surrounded by several
layers of smooth muscle cells. The smooth muscle
layer associated with the acinar epithelial cells, which
express lower levels of AM, is less conspicuous (Nem-
eth and Lee 1996). In human prostate, smooth muscle
cells are disposed around the basal compartment
(Luke and Coffey 1994) of the glandular epithelium;
AM is particularly abundant in the basal cells. Fur-
thermore, the contraction of the smooth muscle cells
in human prostate is believed to be related to the con-
trol of glandular fluid secretion (Luke and Coffey
1994). The spatial localization of AM in the prostate
suggests that AM could be involved in the control of
prostate secretion via regulation of duct muscle tone.
As shown by our results, PAMP expression in pros-
tate is restricted to NE (in human) or NE-like (in rat)
cells. PAMP immunoreactivity was undetectable by
Western blotting. This is not surprising, given the
small number of cells bearing this immunoreactivity as
assessed by immunohistochemistry in this region of
the rat prostate.
In humans, PAMP-positive cells represent a sub-
group of serotonin-positive cells that belong to the
larger population of NE cells expressing chromogra-
nin A. Until now, the presence of PAMP in endocrine
cells has not been described except for the adrenals
and the pituitary (Montuenga et al. 1998). It is re-
markable that the distribution of AM and PAMP im-
munoreactivities does not coincide either in human or
in rat prostate. These differences in the localization of
expression of both peptides suggest either a specific
post-translational processing of the preproAM or an
alternative mRNA splicing mechanism, depending on
the cell type. A similar specific regulation of the ex-
pression of AM and PAMP has been suggested for
other organs, such as the pituitary (Montuenga et al.
1998).
PAMP acts as a vasodilator, a function shared with
AM (Kitamura et al. 1993a,1994), and inhibits neu-
rotransmission (Shimosawa et al. 1995). However, its
presence in human NE cells leads to the suggestion
that PAMP may also regulate local cell function as a
paracrine peptide. Some regulatory substances have
been previously described in NE cells of human pros-
tate, including serotonin, thyroid-stimulating hor-
mone (TSH), somatostatin (Luke and Coffey 1994),
calcitonin, CGRP, and katacalcin (Di Sant’Agnese et
al. 1989).
In rats, the study of the location and possible func-
tion of NE cells has received very little attention. An-
gelsen et al. (1997) did not find chromogranin A in the
lobes of the rat prostate complex using different tech-
niques. This is in agreement with our findings in which
NE-like cells are virtually nonexistent in this area.
However, our results very clearly show that NE-like
cells are present in the prostate, although they are
mostly restricted to prostate urethra and periurethral
ducts.
We have described four subpopulations of NE-like
cells in rat prostate according to their immunoreactive
properties. The four groups of cells show respectively
immunoreactivity for: (a) serotonin, (b) serotonin and
PAMP, (c) serotonin and chromogranin A, and (d)
AM. Two main differences were found between rat
and human NE cells. First, in rats, chromogranin
A-positive cells do not coincide with those positive for
PAMP. In fact, chromogranin A cells are very scarce,
being only a subpopulation of the serotonin-immu-
noreactive cells. Second, there is a subpopulation of
NE-like cells positive for AM in rat (not in human)
but they are not immunostained for chromogranin A.
These results are consistent with the two antisera we
have employed for detecting chromogranin A. Simi-
larly to humans, PAMP-positive cells in rat prostate
also constitute a subpopulation of serotonin-positive
cells. The co-localization of PAMP and serotonin in
the same cells implies that both factors are connected
in rat and human prostate and that they may therefore
contribute to regulation of the same physiological
phenomena.
Some observations related to the techniques merit
discussion. We have verified that Bouin’s fixation is
better than formalin fixation to detect NE cells (but
not to demonstrate AM immunoreactivity in the other
epithelial cells) of the rat prostate. This is in accor-
dance with previous observations reported in human
prostate for other substances (Abrahamsson et al.
1987). Microwave pretreatment enhanced the staining
of all the antibodies used in our study, both after
Bouin’s and after formalin fixation. Using this treat-
ment for ISH in human tissues, a decrease in back-
ground and signal enhancement (when used with pro-
teinase K) were found. For rat prostate, microwave
heating decreases the background but also decreases
the staining. Therefore, the use of the optimal pre-
treatment has great importance for the in situ detec-
tion of AM, PAMP, other related peptides, and their
respective mRNAs.
In summary, AM, AM-R, and PAMP have been
found in several cell types of rat and human prostate.
Figure 16 Demonstration by RT-PCR of mRNA for (A) preproAM
and (B) AM-R in extracts of rat prostate.
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Their distributions and the functions attributed to
these regulatory peptides suggest that they may be rel-
evant in normal biology of the prostate and could be
the target for new studies aimed to assess their in-
volvement in prostate physiology and pathology.
Acknowledgments
Supported by the Spanish Ministry of Education (DGICYT
PB93-0711).
We thank Dr L. Santamaría (Department of Morphology,
Universidad Autónoma de Madrid) for providing the normal
human prostate tissues. We also thank I. Ordoqui and A.
Urbiola for technical assistance, J. Lecanda and Dr J.A. Ro-
dríguez for help in the performance of RT-PCR, and Drs M.
García and C. García–Corchón for technical advice on ISH.
Note Added in Proof
After this article went to press, a new report appeared
demonstrating that AM message is abundant in rat prostate
epithelial cells and that it is regulated by androgens [Pewitt
EB, Haleem R, Wang Z (1999) Endocrinology 140:2382–
2386].
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